2020
DOI: 10.1177/2049463720941053
|View full text |Cite
|
Sign up to set email alerts
|

Radiofrequency denervation of the lumbar facet joints: guidelines for the RADICAL randomised controlled trial

Abstract: Background and aim: The RADICAL trial has been funded by the National Institute for Health Research (NIHR) to evaluate the clinical and cost-effectiveness of radiofrequency denervation (RFD) for low back pain. Recommendations have been published which aim to standardise selection of patients and RFD technique. However, it is important to ensure these recommendations are acceptable to clinicians within the context of the trial. The aim of this work was to develop standardised criteria for the trial entry and RF… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…Findings from the RADICAL trial will contribute to shaping clinical guidelines and service provision for patients living with chronic LBP. Study training resources, developed in line with the consensus-based best practice guidelines for RFD produced by the RADICAL team, 23 have been positively received and taken up by clinicians across the country, demonstrating that the trial is already impacting on RFD provision by improving standards. The study opened to recruitment on 27 May 2022 and is currently recruiting across 17 centres.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Findings from the RADICAL trial will contribute to shaping clinical guidelines and service provision for patients living with chronic LBP. Study training resources, developed in line with the consensus-based best practice guidelines for RFD produced by the RADICAL team, 23 have been positively received and taken up by clinicians across the country, demonstrating that the trial is already impacting on RFD provision by improving standards. The study opened to recruitment on 27 May 2022 and is currently recruiting across 17 centres.…”
Section: Discussionmentioning
confidence: 99%
“…Positive response to a single diagnostic MNBB with no steroids administered. Based on the outcome of a meeting of RADICAL clinicians, 23 a positive response is defined as ≥60% pain relief in the first 24 hours, based on patient-reported assessment. Final eligibility will be met if a patient’s pain returns to ≥5 on a 0–10 Numeric Rating Scale (NRS) after MNBB.…”
Section: Methods and Analysismentioning
confidence: 99%
See 1 more Smart Citation